Digest Network Come funziona
Network
/
Società
Sk
Non verificato

SkylineDx

Di cosa scriviamo

BiologiaFarmaceuticaSanitàScienzaStart-up

13 comunicati stampa

Guarda tutti i comunicati
22/07/2025
Salute
Fitness
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
SkylineDx's Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
08/07/2025
Salute
Fitness
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Independent Meta-Analysis Shows SkylineDx's Merlin CP-GEP Assay Accurately Stratifies Patients for Sentinel Lymph Node Biopsy Selection
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
02/06/2025
Farmaceutica
Sanità
Scienza
SkylineDx Highlights Merlin Assay's Power to Predict Recurrence Risk of Head and Neck Melanoma Without Sentinel lymph node Biopsy at ASCO 2025
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
04/04/2025
Farmaceutica
Sanità
Biologia
SkylineDx Presents Landmark Study on Merlin CP-GEP beyond SLNB prediction: Transforming Melanoma Risk Assessment
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
28/03/2025
Farmaceutica
Sanità
Scienza
Biologia
SkylineDx presents landmark findings from the largest prospective multicenter melanoma GEP trial at SSO 2025
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
12/03/2025
Farmaceutica
Sanità
Economia
Start-up
Biologia
SKYLINEDX ANNOUNCES NEW STUDY DEMONSTRATING ENHANCED RISK STRATIFICATION FOR SENTINEL LYMPH NODE BIOPSY IN HEAD AND NECK MELANOMA USING THE ADVANCED MERLIN CP-GEP TEST
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
28/02/2025
Farmaceutica
Sanità
Biologia
SKYLINEDX ANNOUNCES NEW PUBLICATION ON SKY92 GENE EXPRESSION PROFILING TEST in DEFINING ULTRA-HIGH-RISK MULTIPLE MYELOMA
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
07/12/2024
Farmaceutica
Sanità
Scienza
New Data from PROMMIS Study Highlights the Power of SKY92 in Identifying High-Risk Multiple Myeloma Patients
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
24/10/2024
Farmaceutica
Sanità
Biologia
Independent meta-analyses by Melanoma Institute of Australia on CP-GEP model in Melanoma Care
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0
13/10/2024
Farmaceutica
Sanità
Economia
Start-up
SkylineDx Announces Data from Largest Prospective Multi-Center Melanoma Gene Expression Profiling Trial at 21st International Congress of the Society for Melanoma Research
Fonte
SkylineDx
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0